ProfileGDS4718 / 220755_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 86% 88% 96% 87% 89% 96% 98% 89% 89% 86% 86% 93% 94% 96% 95% 93% 92% 97% 98% 97% 89% 90% 88% 89% 89% 97% 87% 99% 89% 96% 97% 97% 89% 84% 99% 99% 95% 94% 91% 96% 89% 97% 98% 98% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.6858586
GSM549102patient 115, normal, homogenized [OPG study]8.7851188
GSM549104patient 119, normal, homogenized [OPG study]10.517296
GSM549108patient 138, normal, homogenized [OPG study]8.6574887
GSM549119patient 077, normal, homogenized [OPG study]9.0310989
GSM549133patient 032, cancer, homogenized [OPG study]10.502596
GSM549139patient 042, cancer, homogenized [OPG study]11.195398
GSM549099patient 107, normal, homogenized [OPG study]9.0072389
GSM549109patient 139, normal, homogenized [OPG study]8.992289
GSM549110patient 046, normal, homogenized [OPG study]8.5539186
GSM549114patient 063, normal, homogenized [OPG study]8.7213386
GSM549122patient 082, normal, homogenized [OPG study]9.7839193
GSM549134patient 033, cancer, homogenized [OPG study]10.000394
GSM549136patient 036, cancer, homogenized [OPG study]10.59496
GSM549140patient 044, cancer, homogenized [OPG study]10.338295
GSM549111patient 047, normal, homogenized [OPG study]9.7841593
GSM549113patient 057, normal, homogenized [OPG study]9.6806892
GSM549132patient 031, cancer, homogenized [OPG study]11.004597
GSM549137patient 038, cancer, homogenized [OPG study]11.262698
GSM549142patient 047, cancer, homogenized [OPG study]10.438297
GSM549100patient 110, normal, homogenized [OPG study]8.9501789
GSM549107patient 135, normal, homogenized [OPG study]9.2784990
GSM549115patient 068, normal, homogenized [OPG study]9.0261788
GSM549116patient 072, normal, homogenized [OPG study]9.1490789
GSM549120patient 078, normal, homogenized [OPG study]9.080289
GSM549131patient 030, cancer, homogenized [OPG study]10.764897
GSM549118patient 074, normal, homogenized [OPG study]8.7462187
GSM549129patient 027, cancer, homogenized [OPG study]11.869399
GSM549123patient 088, normal, homogenized [OPG study]9.1054289
GSM549124patient 006, cancer, homogenized [OPG study]10.433196
GSM549126patient 015, cancer, homogenized [OPG study]10.970497
GSM549128patient 025, cancer, homogenized [OPG study]10.75297
GSM549103patient 117, normal, homogenized [OPG study]8.8735189
GSM549117patient 073, normal, homogenized [OPG study]8.4620184
GSM549138patient 041, cancer, homogenized [OPG study]11.976699
GSM549141patient 045, cancer, homogenized [OPG study]12.620899
GSM549130patient 028, cancer, homogenized [OPG study]10.114795
GSM549101patient 111, normal, homogenized [OPG study]9.827694
GSM549105patient 128, normal, homogenized [OPG study]9.3458991
GSM549106patient 134, normal, homogenized [OPG study]10.776996
GSM549112patient 048, normal, homogenized [OPG study]9.0225989
GSM549125patient 011, cancer, homogenized [OPG study]10.820797
GSM549127patient 024, cancer, homogenized [OPG study]11.110598
GSM549135patient 035, cancer, homogenized [OPG study]11.535398